Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

January 24, 2013

Primary Completion Date

November 19, 2013

Study Completion Date

November 19, 2013

Conditions
Hyperlipidemia
Interventions
BIOLOGICAL

Evolocumab

Subcutaneous injection

DRUG

Placebo to Evolocumab

Subcutaneous injection

DRUG

Ezetimibe

Tablet for oral administration

DRUG

Placebo to Ezetimibe

Tablet for oral administration

Trial Locations (58)

1200

Research Site, Brussels

1685

Research Site, Midrand

2015

Research Site, Camperdown

2750

Research Site, Ballerup Municipality

3004

Research Site, Melbourne

4064

Research Site, Milton

4153

Research Site, Reinach

6000

Research Site, Perth

6900

Research Site, Lugano

7100

Research Site, La Louvière

Research Site, Vejle

7130

Research Site, Somerset West

7925

Research Site, Observatory

9000

Research Site, Ghent

Research Site, Aalborg

10029

Research Site, New York

14004

Research Site, Córdoba

27609

Research Site, Raleigh

30338

Research Site, Atlanta

30342

Research Site, Atlanta

31406

Research Site, Savannah

43204

Research Site, Reus

44195

Research Site, Cleveland

44311

Research Site, Akron

45212

Research Site, Cincinnati

49684

Research Site, Traverse City

50009

Research Site, Zaragoza

59037

Research Site, Lille

63110

Research Site, St Louis

64646

Research Site, Heppenheim an der Bergstrasse

69200

Research Site, Vénissieux

73069

Research Site, Norman

75651

Research Site, Paris

77030

Research Site, Houston

79189

Research Site, Bad Krozingen

89052

Research Site, Henderson

89117

Research Site, Las Vegas

89148

Research Site, Las Vegas

90048

Research Site, Los Angeles

91360

Research Site, Thousand Oaks

92691

Research Site, Mission Viejo

95608

Research Site, Carmichael

04210

Research Site, Auburn

L3Y 5G8

Research Site, Newmarket

H8S 2E4

Research Site, Lachine

H9R 3J1

Research Site, Pointe-Claire

01307

Research Site, Dresden

Unknown

Research Site, Hong Kong

Research Site, New Territories

1815 JD

Research Site, Alkmaar

1105 AZ

Research Site, Amsterdam

9713 GZ

Research Site, Groningen

90-368

Research Site, Lodz

04-730

Research Site, Warsaw

L22 0LG

Research Site, Liverpool

NW3 2QG

Research Site, London

TF1 6TF

Research Site, Telford

B71 4HJ

Research Site, West Bromwich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY